SignatureFD’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $938 | Hold |
85
| – | – | ﹤0.01% | 3020 |
|
|
2025
Q1 | $759 | Hold |
85
| – | – | ﹤0.01% | 3091 |
|
|
2024
Q4 | $800 | Hold |
85
| – | – | ﹤0.01% | 3059 |
|
|
2024
Q3 | $685 | Sell |
85
-232
| -73% | -$1.87K | ﹤0.01% | 3047 |
|
|
2024
Q2 | $2.69K | Sell |
317
-269
| -46% | -$2.28K | ﹤0.01% | 2677 |
|
|
2024
Q1 | $5.26K | Sell |
586
-122
| -17% | -$1.09K | ﹤0.01% | 2512 |
|
|
2023
Q4 | $7.96K | Buy |
708
+554
| +360% | +$6.23K | ﹤0.01% | 2348 |
|
|
2023
Q3 | $1.33K | Sell |
154
-13
| -8% | -$112 | ﹤0.01% | 2874 |
|
|
2023
Q2 | $1.73K | Sell |
167
-10
| -6% | -$103 | ﹤0.01% | 2846 |
|
|
2023
Q1 | $1.92K | Sell |
177
-344
| -66% | -$3.73K | ﹤0.01% | 2815 |
|
|
2022
Q4 | $5.85K | Buy |
521
+71
| +16% | +$797 | ﹤0.01% | 2399 |
|
|
2022
Q3 | $5K | Buy |
450
+9
| +2% | +$100 | ﹤0.01% | 2463 |
|
|
2022
Q2 | $4K | Sell |
441
-53
| -11% | -$481 | ﹤0.01% | 2546 |
|
|
2022
Q1 | $5K | Buy |
494
+185
| +60% | +$1.87K | ﹤0.01% | 2506 |
|
|
2021
Q4 | $3K | Buy |
309
+154
| +99% | +$1.5K | ﹤0.01% | 2617 |
|
|
2021
Q3 | $1K | Sell |
155
-5
| -3% | -$32 | ﹤0.01% | 2924 |
|
|
2021
Q2 | $2K | Sell |
160
-198
| -55% | -$2.48K | ﹤0.01% | 2612 |
|
|
2021
Q1 | $7K | Buy |
358
+276
| +337% | +$5.4K | ﹤0.01% | 2022 |
|
|
2020
Q4 | $1K | Hold |
82
| – | – | ﹤0.01% | 2473 |
|
|
2020
Q3 | $1K | Buy |
82
+23
| +39% | +$280 | ﹤0.01% | 2485 |
|
|
2020
Q2 | $1K | Buy |
+59
| New | +$1K | ﹤0.01% | 2372 |
|
|
2018
Q3 | – | Sell |
-200
| Closed | -$5K | – | 2000 |
|
|
2018
Q2 | $5K | Buy |
+200
| New | +$5K | ﹤0.01% | 1565 |
|